These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 31494395)

  • 1. The impact of age on the outcome of patients treated with radiotherapy for mucoepidermoid carcinoma (MEC) of the salivary glands in the head and neck: A 15-year single-center experience.
    Akbaba S; Heusel A; Mock A; Held T; Lang K; Hoerner-Rieber J; Forster T; Katayama S; Kargus S; Rieken S; Plinkert P; Herfarth K; Debus J; Adeberg S
    Oral Oncol; 2019 Oct; 97():115-123. PubMed ID: 31494395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a combination treatment with intensity modulated radiotherapy and active raster-scanning carbon ion boost for adenoid cystic carcinoma of the minor salivary glands of the nasopharynx.
    Akbaba S; Ahmed D; Lang K; Held T; Mattke M; Hoerner-Rieber J; Herfarth K; Rieken S; Plinkert P; Debus J; Adeberg S
    Oral Oncol; 2019 Apr; 91():39-46. PubMed ID: 30926061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Outcome of a Combined Dose-Escalated Treatment Regime With Helical TomoTherapy® and Active Raster-Scanning Carbon Ion Boost for Adenocarcinomas of the Head and Neck.
    Akbaba S; Mock A; Hoerner-Rieber J; Held T; Katayama S; Forster T; Freudlsperger C; Rieken S; Herfarth K; Plinkert P; Debus J; Adeberg S
    Front Oncol; 2019; 9():755. PubMed ID: 31475108
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival.
    Jensen AD; Nikoghosyan AV; Poulakis M; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J
    Cancer; 2015 Sep; 121(17):3001-9. PubMed ID: 26043145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experience.
    Katsoulakis E; Riaz N; Hu M; Morris L; Sherman E; McBride S; Lee N
    Laryngoscope; 2016 Mar; 126(3):620-6. PubMed ID: 26597398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term results of postoperative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of Squamous Cell Carcinoma (SCC) located in the oropharynx or oral cavity.
    Hoffmann M; Saleh-Ebrahimi L; Zwicker F; Haering P; Schwahofer A; Debus J; Huber PE; Roeder F
    Radiat Oncol; 2015 Dec; 10():251. PubMed ID: 26637471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?
    Jensen AD; Poulakis M; Vanoni V; Uhl M; Chaudhri N; Federspil PA; Freier K; Krauss J; Debus J
    Radiat Oncol; 2016 Jul; 11(1):90. PubMed ID: 27386864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large German Multicenter Experience on the Treatment Outcome of 207 Patients With Adenoid Cystic Carcinoma of the Major Salivary Glands.
    Akbaba S; Bostel T; Lang K; Bahadir S; Lipman D; Schmidberger H; Matthias C; Rotter N; Knopf A; Freudlsperger C; Plinkert P; Debus J; Adeberg S
    Front Oncol; 2020; 10():593379. PubMed ID: 33262950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly.
    Haehl E; Rühle A; Klink R; Kalckreuth T; Sprave T; Gkika E; Zamboglou C; Meiß F; Grosu AL; Nicolay NH
    Radiat Oncol; 2021 Jun; 16(1):105. PubMed ID: 34118984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
    Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
    Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis.
    Askoxylakis V; Hegenbarth P; Timke C; Saleh-Ebrahimi L; Debus J; Röder F; Huber PE
    Radiat Oncol; 2016 Feb; 11():17. PubMed ID: 26847089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled study comparing simultaneous modulated accelerated radiotherapy versus simultaneous integrated boost intensity modulated radiotherapy in the treatment of locally advanced head and neck cancer.
    Tandon S; Gairola M; Ahlawat P; Rawat S; Aggarwal A; Sharma K; Tiwari S; Karimi AM; Muttagi V; Sachdeva N; Bhushan M
    J Egypt Natl Canc Inst; 2018 Sep; 30(3):107-115. PubMed ID: 29960876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-Modulated Proton and Carbon-Ion Radiation Therapy in the Management of Head and Neck Sarcomas.
    Yang J; Gao J; Qiu X; Hu J; Hu W; Wu X; Zhang C; Ji T; Kong L; Lu JJ
    Cancer Med; 2019 Aug; 8(10):4574-4586. PubMed ID: 31231939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer.
    Vlacich G; Stavas MJ; Pendyala P; Chen SC; Shyr Y; Cmelak AJ
    Radiat Oncol; 2017 Jan; 12(1):13. PubMed ID: 28086954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity Modulated Radiotherapy (IMRT) With Carbon Ion Boost in the Multimodal Treatment of Salivary Duct Carcinoma.
    Adeberg S; Windisch P; Ehret F; Baur M; Akbaba S; Held T; Bernhardt D; Haefner MF; Krauss J; Kargus S; Freudlsperger C; Plinkert P; Flechtenmacher C; Herfarth K; Debus J; Rieken S
    Front Oncol; 2019; 9():1420. PubMed ID: 31921675
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center.
    Al-Mamgani A; van Rooij P; Verduijn GM; Meeuwis CA; Levendag PC
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):189-95. PubMed ID: 22330990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.
    Schoenfeld JD; Sher DJ; Norris CM; Haddad RI; Posner MR; Balboni TA; Tishler RB
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):308-14. PubMed ID: 21075557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.
    Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
    Radiat Oncol; 2017 Aug; 12(1):131. PubMed ID: 28810885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
    Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
    Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bimodal Radiotherapy with Active Raster-Scanning Carbon Ion Radiotherapy and Intensity-Modulated Radiotherapy in High-Risk Nasopharyngeal Carcinoma Results in Excellent Local Control.
    Akbaba S; Held T; Lang K; Forster T; Federspil P; Herfarth K; Häfner M; Plinkert P; Rieken S; Debus J; Adeberg S
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30884910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.